Global TradFi & Macroeconomics

Focus on price action and volatility across stocks, bonds, forex, commodities, and major indices. Analyze macro indicators like interest rates, inflation, employment, and policy expectations to decode global liquidity shifts, risk sentiment, and cross-market correlations.
All
Stocks
Metals
Indices
Forex
Commodities

China's SAFE Moves to Release New Round of QDII Quota Shortly

According to a statement from China's State Administration of Foreign Exchange (SAFE) at a press conference on July 17, the regulator is accelerating preparations to release a new round of Qualified Domestic Institutional Investor (QDII) quotas in the near term. SAFE Capital Account Division
GateNews·07-17 02:49
China's SAFE Moves to Release New Round of QDII Quota Shortly

Netflix’s Q3 guidance missed expectations, and NFLX stock fell 8.84% after hours

Netflix (NFLX) shares fell 8.84% (-$6.57) in after-hours trading on July 16, closing at $67.78. This came after the company released its Q3 2026 guidance, which came in below market expectations: Netflix expects Q3 revenue of $12.86 billion, below Wall Street’s $13.0 billion estimate; its Q3 EPS guidance is $0.82, below analysts’ expectations. Netflix Q2 EPS of $0.80, revenue of $12.56 billion According to Netflix’s Q2 2026 earnings report, key financial metrics are as follows: EPS: $0.80 (analy
NFLX-1.13%
MarketWhisper·07-17 02:46
Netflix Q3指引不如預期

SpaceX Starship’s 13th flight was aborted at the last moment, causing SPCX stock to fall below its offering price.

SpaceX (SPCX) shares closed on July 16 at $131.11, down 3.1%, and for the first time fell below its $135 IPO issue price. That same day, Starship’s 13th flight from Starbase in the southern part of Texas stopped its countdown when the Super Heavy booster engines had just begun ignition. SpaceX spokesperson Dan Huot said engineers will inspect the issue before scheduling a new attempt. Record of the Cancellation of Starship Flight 13 Around 6:45 p.m. Eastern Time on July 16, 2026, the launch coun
SPCX7.33%
ASTS2.43%
GOOG1.63%
BTC-2.07%
MarketWhisper·07-17 02:40
SpaceX星艦第13次飛行最後一刻中止

The first global oral PCSK9 inhibitor, Lipfendra, has been approved; MRK stock jumps 3.3%

Merck (MRK) shares closed up 3.3% to $127.63 on July 16. Earlier, U.S. regulators approved Lipfendra to become the first—and only—daily oral PCSK9 inhibitor tablet worldwide, which can reduce low-density lipoprotein cholesterol (LDL) by up to 60%, with no contraindication or allergy warning. Lipfendra Approval Snapshot: First Oral PCSK9 Tablet, LDL Down 60% According to the approval announcement, Lipfendra is the first and only daily oral PCSK9 inhibitor tablet globally. Its mechanism of action
MRK0.34%
AMGN-1.04%
REGN0.17%
SNY-1.79%
MarketWhisper·07-17 02:36
全球首個口服PCSK9抑制劑Lipfendra獲批